In some of the most significant international cannabis legislation of 2015, Germany [in late 2015] approved the creation of a special government agency to oversee the production of medicinal cannabis in the European nation. This progressive move puts the German government in the business of producing and making available high-quality medicinal cannabis via safe access to thousands of its severely ill citizens.
“This paves the way for the first cultivation of medicinal cannabis in Germany,”
wrote the German Hemp Association (Deutscher Hanfverband, or DHV) in a press release, which continued, “[this] helps not only…patients, but allows also new economic prospects for Germany.”
The legislation does not, however, allow individual Germans to grow their own cannabis medicine. It also limits legal availability of cannabis to a very small group of patients, covering only two ailments.
